The FDA has explicitly stated that pharmacies should not compound semaglutide salts for weight loss
In clinical trials of FDA-approved GLP-1 medications used under medical supervision, some patients achieved average losses consistent with 4 to 8 pounds per month over time, with a total weight loss of roughly 15% to 21% of body weight over the full treatment course
At Tulsi Wellness Club, our team will work with you to assess your health goals and create a personalized treatment plan
In January 2026 , the U.S
Target two-hour after-meal (postprandial) glucose levels For people with diabetes whose A1C levels are not at goal despite fasting glucose levels being within the targeted range (80 130 mg/dL), the ADA suggests assessment of two-hour after-meal (postprandial) glucose levels, with a targeted level of less than 180 mg/dL (ADA 2021a)
Youll also be more likely to keep your energy high, even as you cut your caloric intake